RÉSUMÉ
Vitreomacular traction syndrome results from persistent vitreoretinal adhesions in the setting of partial posterior vitreous detachment (PVD). Vitrectomy and reattachment of retina is an effective therapeutic approach. The adhesion between vitreous cortex and internal limiting membrane (ILM) of the retina is stronger in youth, which brings difficulties to induce PVD in vitrectomy. Several clinical investigations demonstrated that intravitreous injection of plasmin before vitrectomy could reduce the risk of detachment. In our study, a novel recombinant human microplasminogen (rhµPlg) was expressed by Pichia pastoris. Molecular docking showed that the binding of rhµPlg with tissue plasminogen activator (t-PA) was similar to plasminogen, suggesting rh µPlg could be activated by t-PA to generate microplasmin (µPlm). Moreover, rhµPlg had higher catalytic activity than plasminogen in amidolytic assays. Complete PVD was found at vitreous posterior pole of 125 µg rhµPlg-treated eyes without morphological change of retina in juvenile rabbits via intraocular injection. Our results demonstrate that rhµPlg has a potential value in the treatment of vitreoretinopathy.
Sujet(s)
Rétinopathies , Décollement du vitré , Animaux , Humains , Lapins , Adolescent , Décollement du vitré/traitement médicamenteux , Activateur tissulaire du plasminogène/métabolisme , Activateur tissulaire du plasminogène/pharmacologie , Corps vitré/métabolisme , Simulation de docking moléculaire , Rétine , Vitrectomie/méthodes , Plasminogène/métabolisme , Plasminogène/pharmacologie , Injections oculaires , Rétinopathies/métabolisme , Protéases à sérineRÉSUMÉ
BACKGROUND: Patients with acute non-lacunar single subcortical infarct (SSI) associated with mild intracranial atherosclerosis (ICAS) have a relatively high incidence of early neurological deterioration (END), resulting in unfavorable functional outcomes. Whether the early administration of argatroban and aspirin or clopidogrel within 6-12 h after symptom onset is effective and safe in these patients is unknown. METHODS: A review of the stroke database of Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University and Qingdao Center Hospital, Qingdao University Medical College in China was undertaken from May 2017 to January 2020 to identify all patients with non-lacunar SSI caused by ICAS within 6-12 h of symptom onset based on MRI screening. Patients were divided into two groups, one comprising those who received argatroban and mono antiplatelet therapy with aspirin or clopidogrel on admission (argatroban group), and the other those who received dual antiplatelet therapy (DAPT) with aspirin and clopidogrel during hospitalization (DAPT group). The primary outcome was recovery by 90 days after stroke based on a modified Rankin scale (mRS) score (0 to 1). The secondary outcome was END incidence within 120 h of admission. Safety outcomes were intracranial hemorrhage (ICH) and major extracranial bleeding. The probability of clinical benefit (mRS score 0-1 at 90 days) was estimated using multivariable logistic regression analysis. RESULTS: A total of 304 acute non-lacunar SSI associated with mild ICAS patients were analyzed. At 90 days, 101 (74.2%) patients in the argatroban group and 80 (47.6%) in the DAPT group had an mRS score that improved from 0 to 1 (P < 0.001). The relative risk (95% credible interval) for an mRS score improving from 0 to 1 in the argatroban group was 1.50 (1.05-2.70). END occurred in 10 (7.3%) patients in the argatroban group compared with 37 (22.0%) in the DAPT group (P < 0.001). No patients experienced symptomatic hemorrhagic transformation. CONCLUSIONS: Early combined administration of argatroban and an antiplatelet agent (aspirin or clopidogrel) may be beneficial for patients with non-lacunar SSI associated with mild ICAS identified by MRI screening and may attenuate progressive neurological deficits. TRIAL REGISTRATION: Our study is a retrospectively registered trial.
Sujet(s)
Artériosclérose intracrânienne , Antiagrégants plaquettaires , Accident vasculaire cérébral lacunaire , Arginine/analogues et dérivés , Association de médicaments , Humains , Artériosclérose intracrânienne/imagerie diagnostique , Artériosclérose intracrânienne/traitement médicamenteux , Acides pipécoliques/usage thérapeutique , Antiagrégants plaquettaires/usage thérapeutique , Accident vasculaire cérébral lacunaire/imagerie diagnostique , Accident vasculaire cérébral lacunaire/traitement médicamenteux , Sulfonamides/usage thérapeutique , Résultat thérapeutiqueRÉSUMÉ
OBJECTIVE: Brain-derived neurotrophic factor (BDNF) plays a potential role in stroke recovery, as it promotes plasticity. The aim of this study is to investigate the association between infarct volume using DWI and BDNF at admission in patients with acute ischemic stroke (AIS). METHODS: The study population comprised consecutive patients with an AIS diagnosis who had been referred to our hospital between January 2015 and June 2016. The severity of stroke was evaluated by the National Institutes of Health Stroke Scale (NIHSS) at admission. Infarct volumes indicated by DWI were measured with MIPAV software. The relationship between median DWI infarct volume and serum BDNF level quartiles was evaluated using a semiparametric approach with univariate and multivariate quartile regression analysis. RESULTS: In this study, 270 patients were included and met the study criteria. The median DWI infarct volumes for the serum BDNF level quartiles (lowest to highest) were 10.56, 5.13, 3.75 and 2.43ml. Nonparametric Spearman rank correlation revealed a statistically significant negative correlation between serum BDNF level and DWI infarct volume (r=-0.363; P<0.001). The median DWI infarct volume in the lowest BDNF quartile was significantly larger than those in the upper 3 quartiles (P<0.001). Further, median adjusted DWI infarct volumes (IQR) for each of the BDNF level quartiles were 7.77, 4.56, 3.75, and 2.43ml from lowest to highest quartiles. CONCLUSIONS: Larger stroke infarct volumes using DWI are associated with lower levels of BDNF at admission. Further investigations are suggested to elucidate the role of BDNF as part of a potential neuroprotective strategy.
Sujet(s)
Infarctus encéphalique/imagerie diagnostique , Infarctus encéphalique/étiologie , Facteur neurotrophique dérivé du cerveau/sang , Accident vasculaire cérébral/sang , Accident vasculaire cérébral/complications , Sujet âgé , Glycémie , Encéphalopathie ischémique/complications , Protéine C-réactive/métabolisme , Études cas-témoins , Imagerie par résonance magnétique de diffusion , Femelle , Homocystéine/sang , Humains , Mâle , Adulte d'âge moyen , Études rétrospectives , Accident vasculaire cérébral/imagerie diagnostique , Accident vasculaire cérébral/étiologieRÉSUMÉ
OBJECTIVE: To analyze the distribution and treatment of aryepiglottic fold diseases. METHODS: The clinical data of the inpatients with aryepiglottic fold diseases at our department from January 2000 to May 2011 were retrospectively evaluated. RESULTS: Among 113 cases, there were benign (n = 108) and malignant (n = 5) diseases. The three major symptoms were abnormal sensation of throat (n = 79), hoarseness (n = 29) and throat pain (n = 26). Among 108 benign cases, there were surgery under direct laryngoscopy (n = 100), aryepiglottic fold hemangioma undergoing laser under indirect laryngoscopy (n = 4), one with cyst and another with hemangioma undergoing tumor removal via an external thyrohyoid membrane approach (n = 2) and inflammation of aryepiglottic fold undergoing conservative treatment (n = 2). Among 5 malignant tumors, the procedures included total laryngectomy (n = 2) and semi-laryngectomy (n = 2). One patient had not any treatment after a definite diagnosis. CONCLUSION: Most aryepiglottic fold diseases are benign. Their major symptoms include abnormal sensation of throat, hoarseness and throat pain. Surgery under direct laryngoscopy is performed for benign diseases while laryngectomy for malignant ones. CO(2), Ho-YAG and KTP laser may also be used.
Sujet(s)
Cartilage aryténoïde , Maladies du larynx/chirurgie , Tumeurs du larynx/chirurgie , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Cartilage aryténoïde/anatomopathologie , Femelle , Humains , Maladies du larynx/diagnostic , Tumeurs du larynx/diagnostic , Laryngoscopie , Lasers à solide , Mâle , Adulte d'âge moyen , Études rétrospectives , Jeune adulteRÉSUMÉ
OBJECTIVE: To characterize the clinical and cardiac MRI features of dilated cardiomyopathy (DCM) and left ventricular noncompaction (LVNC). METHODS: Compared the clinical and MRI features between 25 patients with LVNC and 21 patients with DCM. The MRI derived diastolic left ventricular wall thickness and the number and degree of noncompaction (NC) were evaluated using the 17-segment model. RESULTS: Chest distress, shortness of breath and abnormal ECG were presented in all DCM patients, abnormal ECG was evidenced in 22 LVNC patients and 21 out of 25 LVNC patients presented similar clinical symptoms as DCM patients while the rest 4 LVNC patients were asymptomatic. Left atrial and ventricular dimensions were significantly smaller in LVNC patients compared to DCM patients. The degree of left ventricular (LV) spherical remodeling was significantly greater in patients with DCM (sphericity index, SI = 0.81 +/- 0.06) than in patients with LVNC (SI = 0.74 +/- 0.11, P < 0.05). The LV ejection fraction (LVEF) was significantly higher in patients with LVNC (32.7% +/- 14.2%) than that in patients with DCM (15.0% +/- 5.1%). The number of NC segments in LVNC patients (9 +/- 1) was significantly higher than the number of hypertrabeculation segment in DCM patients (5 +/- 2). The left ventricular apex (the 17th segment) was unexceptionally involved in all LVNC patients, while hypertrabeculation was absent in the 17th segment of DCM patients. The NC was more common in the apical and mid segments (16th, 12th and 11th segments) than in basal and mid septal segments (2nd, 3rd, 8th and 9th segments) in both LVNC and DCM patients. The thickness of compacted myocardium of the segments associated with noncompaction appeared thin in two groups. The wall thickness of noncompaction myocardium segments was thicker in LVNC patients than in DCM patients. The end-diastolic NC/C ratio was, on average, higher in patients with LVNC (3.3 +/- 0.6) than in patients with DCM (1.9 +/- 0.3). CONCLUSIONS: The clinical manifestation is similar while there are significant differences in the morphology and function of left atria and left ventricle between the LVNC and DCM patients. The different distribution and degree of NC were helpful to differentiate LVNC from DCM.
Sujet(s)
Cardiomyopathies/anatomopathologie , Cardiomyopathie dilatée/anatomopathologie , Dysfonction ventriculaire gauche/anatomopathologie , Adolescent , Adulte , Sujet âgé , Enfant , Femelle , Humains , Imagerie par résonance magnétique , Mâle , Adulte d'âge moyen , Jeune adulteRÉSUMÉ
There is a lack of research on volumetric multi-slice CT (MSCT) application in hip densitometric assessment and geometric measures in elderly women with osteoporotic vertebral fractures. A total of 237 elderly women were divided into three groups based on BMD values of the lumbar spine (AP-SPINE) and/or the femoral neck (NECK) by dual energy X-ray absorptiometry (DXA): osteoporosis with (OP_FX, 53 cases) or without vertebral fracture (OP_NONFX, 94 cases), or normal BMD (CONTROL, 90 cases). Volumetric BMD of trabecular bone (TRAB), integral bone (INTGL) and cortical bone (CORT) with neck axis length (NAL) and minimum cross-section area (mCSA) measures of the left femoral neck were calculated, respectively, by using OsteoCAD software based on MSCT scans of the abdominal-pelvic region of all participants, then the index of femoral neck strength (FNSI) was estimated. The values of TRAB, CORT and INTGL of OP_FX were significantly lower than those of OP_NONFX, with the decrease in 6.8-21.8%, as well as being lower than those in CONTROL, whereas no significant differences in the values of AP-SPINE and NECK were found between OP_FX and OP_NONFX. No significant difference of the value of mCSA was found among these three groups. The NAL value of OP_NONFX was larger than that of CONTROL. FNSI of femoral neck in OP_FX (0.42 ± 0.15 g(2)/cm(4)) was significantly lower than OP_NONFX (0.50 ± 0.14 g(2)/cm(4)) (p < 0.05). vQCT measurement seemed to be more effective than DXA in evaluating hip densitometric changes and discriminating osteoporotic elderly subjects with fractured vertebrae from the non-fractured in a group of Chinese women.